# OnLume Surgical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/onlume-surgical

- Industry: Healthcare
- Headquarters: Madison, US
- Website: www.onlume.com/
- Total disclosed funding: $7M
- Latest round: Series A (Apr 30, 2021)
- Investors on record: 3

## About

OnLume Surgical develops advanced fluorescence image-guided surgery systems aimed at enhancing surgical precision. Their innovative technology supports surgeons in visualizing critical structures during operations, particularly in oncology.Founded in 2015, OnLume Surgical operates from Madison, US, focusing on fluorescence image-guided surgery systems. The company was established by Adam Uselmann, Andreas Velten, and Benjamin Titz, with James Bowman serving as CEO. OnLume has successfully raised USD 7 mn in Series A funding on April 30, 2021, led by Cambridge Investments, along with WARF Ventures and Wisconsin Investment Partners, supporting their commercial launch initiatives. The company has completed one deal to date.OnLume Inc. specializes in developing fluorescence image-guided surgery systems designed to enhance surgical precision and outcomes. Their core product employs advanced imaging technology that enables surgeons to visualize critical anatomical structures and assess the extent of disease during operations, even under ambient lighting. This technology is particularly beneficial in oncology for precise tumor identification and delineation. OnLume's systems cater primarily to hospitals and surgical centers in the United States, with plans to expand into international markets, serving surgeons and medical professionals who need enhanced imaging capabilities during procedures.OnLume generates revenue through the direct sale of its fluorescence image-guided surgical systems to medical facilities. The company has raised USD 7 mn in Series A financing to support the commercial launch of its products. Revenue transactions include initial equipment purchases and ongoing partnerships with healthcare providers for training and support services. While specific pricing details are not disclosed, OnLume focuses on establishing long-term client relationships by integrating its technology into surgical workflows, aiming to optimize surgical outcomes and operational efficiency.Following the USD 7 mn Series A funding raised in April 2021, OnLume Surgical plans to utilize this capital for the commercial launch of its fluorescence image-guided surgery systems. The company is focused on expanding its reach into new markets, particularly targeting international surgical centers, and aims to execute these plans within the coming year. The funding will help facilitate their product launch and establish a foothold in the evolving landscape of surgical technology.

## Funding rounds

- Series A, Apr 30, 2021, $7M — Wisconsin Investment Partners, Cambridge Investments, WARF Ventures

## Investors

- Wisconsin Investment Partners (https://capitalatlas.ai/funds/wisconsin-investment-partners) — Series A
- Cambridge Investments — Series A
- WARF Ventures (https://capitalatlas.ai/funds/warf-ventures) — Series A